ADVERTISEMENT

The Orphan Drug Backlash

The Orphan Drug Act of 1983 was supposed to provide incentives for private industry to develop needed, but unprofitable, drugs to treat rare diseases. It has done so, but not without eliciting controversy

THIS ARTICLE IS ONLY AVAILABLE AS A PDF.
or subscribe to access the full article.
Buy Digital Issue $7.99
Digital Issue + All Access Subscription $99.99 Subscribe
Share this Article:

Comments

You must sign in or register as a ScientificAmerican.com member to submit a comment.

Email this Article

X